FDA Gives Firms With RiskMAP Drugs 6 Months To Submit Strategy Proposals

Makers of 16 approved drugs have until Sept. 21 to submit Risk Evaluation and Mitigation Strategy proposals to FDA.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet